Moderna, Inc. officer Shannon Thyme is set to sell 1,319 shares of the company's common stock on 08/28/2024, according to a recent filing. The shares to be sold were acquired on 08/27/2024 as part of a restricted stock vesting and are considered compensation for Thyme's role at Moderna. The aggregate market value of the shares to be sold is reported at $104,721.87. This transaction follows a series of sales over the past three months, where Thyme sold a total of 6,779 shares, amounting to gross proceeds of $1,020,962.62.

Moderna, Inc. officer Shannon Thyme is set to sell 1,319 shares of the company's common stock on 08/28/2024, according to a recent filing. The shares to be sold were acquired on 08/27/2024 as part of a restricted stock vesting and are considered compensation for Thyme's role at Moderna. The aggregate market value of the shares to be sold is reported at $104,721.87. This transaction follows a series of sales over the past three months, where Thyme sold a total of 6,779 shares, amounting to gross proceeds of $1,020,962.62.